VIR BIOTECHNOLOGY, I

VIR
Real-time Estimate Quote. Real-time Estimate  - 06/22 12:34:22 pm
48USD -2.26%

Vir Biotechnology : GlaxoSmithKline's COVID-19 Drug Candidate Under Review in Europe

04/15/2021 | 10:42am
MarketScreener.com
This article is reserved for subscribers
A "one-stop shopping" service for investors
The best opportunities, portfolios, and screeners
Discover